HOME › DRUGS › HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)
ACTIVE SUBSTANCE / INN

HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)

Brand name(s): Cervarix
EMA LISTED
AUTHORISED
Papillomavirus Infections;Uterine Cervical Dysplasia;Immuniz…
ACTIVE SUBSTANCE
Human Papillomavirus Vaccine [Types 16, 18] (Recombinant, Adjuvanted, Adsorbed)
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CervarixGlaxoSmithKline Biologicals S.A.Authorised20/09/2007Papillomavirus Infections;Uterine Cervical Dysplasia;Immunization

FULL INTELLIGENCE ON HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →